Engineered Monoclonal Antibody VYD222 Potently Neutralizes Broad SARS-CoV-2 Variants
A structural analysis reveals how the engineered antibody VYD222 overcomes spike mutations to neutralize diverse SARS-CoV-2 variants.
A structural analysis reveals how the engineered antibody VYD222 overcomes spike mutations to neutralize diverse SARS-CoV-2 variants.
A sequential heavy-chain preselection and remating workflow in yeast surface display increases light-chain sampling depth by an estimated 500-fold without ...
A linear doggybone DNA vaccine candidate demonstrated significantly higher antibody titres, broader cellular activation, and more durable immune memory than ...
A sero-epidemiological study conducted in Mozambique and Spain has identified serological cross-reactivity between antibodies targeting Plasmodium falciparum and SARS-CoV-2 in ...
A multicentre phase II trial found that co-administering the monoclonal antibody AZD7442 and a bivalent vaccine was well tolerated in ...
A computational study demonstrates that AI-guided and structure-based redesign of Sotrovimab can enhance predicted binding affinity against SARS-CoV-2 Omicron BA.2 ...
A genomic and structural modeling study of Brazilian bats has identified unclassified alphacoronaviruses carrying a divergent spike protein that retains ...
Cryo-EM and functional assays show that the JN.4-specific A475V substitution remodels the SARS-CoV-2 RBD large loop and reduces ACE2-binding affinity ...
A new PLOS Biology study shows that the breadth of ACE2 receptor usage among bat sarbecoviruses predicts both their host ...
Researchers have mapped conserved epitopes on the sarbecovirus spike protein that allow three monoclonal antibodies to neutralize a wide range ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine